Immunophenotypically, the CML blasts can be distinguished from normal hematopoietic stem cells by the co-expression of dipeptidylpeptidase IV (DPPIV, CD26).32 This evidence concerns the gene DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive.